Globus Medical (GMED)
NYSE · Healthcare · Medical Devices
Globus Medical is a Healthcare company with a market capitalization of $11.15B and a trailing P/E ratio of 21.0.
5-Year Price History
Latest Annual Financials · FY ending December 31, 2025
Recent Quarterly Earnings (EPS)
| Quarter | Reported | Actual EPS | Estimate | Surprise |
|---|---|---|---|---|
| Q1 2026 | May 7, 2026 | $1.12 | $0.92 | +21.7% |
| Q4 2025 | February 24, 2026 | $1.28 | $1.15 | +11.0% |
| Q3 2025 | November 6, 2025 | $1.18 | $0.78 | +51.3% |
| Q2 2025 | August 7, 2025 | $0.86 | $0.76 | +13.2% |
| Q1 2025 | May 8, 2025 | $0.68 | $0.75 | -9.3% |
| Q4 2024 | February 20, 2025 | $0.84 | $0.75 | +12.2% |
Short Interest
FINRA-reported short interest for semi-monthly settlement dates, published about nine business days after each settlement. Share counts are adjusted to the current split basis.
| Settlement | Shares Short | % of Shares Out | Days to Cover | Change |
|---|---|---|---|---|
| July 15, 2026 | 7,069,160 | 5.12% | 3.5 | -4.6% |
| June 30, 2026 | 7,409,990 | 5.36% | 3.6 | +35.5% |
| June 15, 2026 | 5,469,519 | 3.96% | 3.4 | +39.6% |
| May 29, 2026 | 3,916,683 | 2.83% | 1.9 | +14.7% |
| May 15, 2026 | 3,414,228 | 2.47% | 1.6 | +9.4% |
| April 30, 2026 | 3,120,512 | 2.27% | 3.5 | -5.8% |
| April 15, 2026 | 3,313,920 | 2.42% | 2.9 | +17.1% |
| March 31, 2026 | 2,831,226 | 2.06% | 2.9 | -14.1% |
Other Medical Devices Stocks
Frequently Asked Questions
What is Globus Medical's market cap?
As of August 13, 2026, Globus Medical (GMED) has a market capitalization of $11.15B.
What is Globus Medical's P/E ratio?
Globus Medical trades at a trailing price-to-earnings (P/E) ratio of 21.0. Its forward P/E is 18.1.
Does Globus Medical pay a dividend?
Globus Medical does not currently pay a dividend.
What sector is GMED in?
Globus Medical is in the Healthcare sector, specifically the Medical Devices industry.
What is Globus Medical's short interest?
As of the July 15, 2026 FINRA settlement, 7,069,160 GMED shares were sold short, or 5.12% of shares outstanding. Days to cover: 3.5. FINRA publishes short interest twice a month, about nine business days after each settlement date.
What was Globus Medical's revenue?
In its latest reported fiscal year (ending December 31, 2025), Globus Medical reported revenue of $2.94B and net income of $537.90M.
Ask your own questions about GMED
Try mrmarket.ai freeData as of August 13, 2026. Figures are sourced from company filings and market data and may be delayed or revised. For informational purposes only — not investment advice.